Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04267237 |
Title | A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries |
Facility | Status | City | State | Zip | Country | Details |
---|